4586.T
Medrx Co.,Ltd.
グロース · 医薬品 · 医薬品 · JP
JPY 58.00
−3.33%Year over year
Reported trailing growth
- Revenue
- -50.2%
- EBITDA
- —
- EBIT
- -18.7%
- EPS
- +0.3%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -4.7%
- EBITDA
- —
- EPS
- -20.2%
Three-year CAGR
- Revenue
- +29.5%
- EBITDA
- -22.9%
- EBIT
- -18.7%
- Net income
- -16.3%
- EPS
- +6.0%
- Free cash flow
- -20.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026